As inflammation is instrumental in tumor development in CAC, the ability of FIBCD1 to modulate and dampen inflammatory responses in the intestinal tract may be one of its primary anti-tumorigenic actions observed in the AOM/DSS model. The gene discussed is FIBCD1; the disease is neoplasm.